Jiangsu Apon Medical Technology Co. Ltd. Class A

Jiangsu Apon Medical Technology Co. Ltd. Class A

SSZSE:300753
18.84
CNY
-1.07
(-5.37%)
-0.27EPS
2.60BMarket Cap
Apr 29Next Earn

Total Valuation

CNY

As of September 30, 2026, Jiangsu Apon Medical Technology Co. Ltd. Class A carries a market capitalization of 2.60B, placing it among publicly traded companies globally. Its enterprise value stands at 2.66B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap2.60B
Enterprise Value2.66B

Important Dates

Jiangsu Apon Medical Technology Co. Ltd. Class A's next confirmed earnings release is scheduled for April 29, 2027.

Earnings Date4/29/2027

Share Statistics

As of September 30, 2026, Jiangsu Apon Medical Technology Co. Ltd. Class A has 126.05M shares outstanding.

Shares Outstanding126.05M

Valuation Ratios

These figures are as of September 30, 2026. The price-to-sales ratio is 8.09, and the price-to-book ratio stands at 4.00.

PS Ratio8.09
PB Ratio4.00
P/TBV Ratio4.92

Enterprise Valuation

These figures are as of September 30, 2026. The EV/Sales ratio of 8.26 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 2.66B versus a market cap of 2.60B, with the gap driven by net debt and cash on the balance sheet.

EV / Sales8.26

Financial Position

As of September 30, 2026, Jiangsu Apon Medical Technology Co. Ltd. Class A maintains a current ratio of 2.02, meaning it holds 2.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 19.26, indicating elevated leverage, while an interest coverage ratio of -11.12 demonstrates limited ability to service its debt obligations.

Current Ratio2.02
Quick Ratio0.54
Debt / Equity19.26
Debt / EBITDA-4.05
Interest Coverage-11.12

Financial Efficiency

CNY

Over the twelve months ended September 30, 2026, Jiangsu Apon Medical Technology Co. Ltd. Class A posted a negative return on equity (ROE) of -4.42, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -3.51, reflecting losses generated across the asset base. The company generates approximately 544,075.50 in revenue per employee across its workforce of 592.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 1.70 indicates how many times Jiangsu Apon Medical Technology Co. Ltd. Class A sells and replaces its inventory over a year, a key working capital efficiency ratio.

Return on Equity (ROE)-4.42
Return on Assets (ROA)-3.51
Revenue Per Employee544,075.50
Employee Count592.00
Inventory Turnover1.70

Taxes

CNY

Over the twelve months ended September 30, 2026, Jiangsu Apon Medical Technology Co. Ltd. Class A recorded 748,292.54 in income tax expense. The company reported a pretax loss of -33.23M and -29.26M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

Income Tax748,292.54

Stock Price Statistics

CNY

As of the close on November 17, 2026, Jiangsu Apon Medical Technology Co. Ltd. Class A's stock has declined approximately 32.28% over the past 52 weeks. The 50-day moving average sits at 20.54, while the 200-day moving average is 24.86.

52-Week Price Change-32.28%
50-Day Moving Average20.54
200-Day Moving Average24.86

Income Statement

CNY

Over the twelve months ended September 30, 2026, Jiangsu Apon Medical Technology Co. Ltd. Class A generated 322.09M in revenue and converted that into -29.26M in net income, yielding earnings per share of -0.27. EBITDA reached -31.46M, while operating income came in at -31.13M.

Revenue322.09M
Gross Profit222.54M
Operating Income-31.13M
Pretax Income-33.23M
Net Income-29.26M
EBITDA-31.46M
EBIT-31.46M
Earnings Per Share (EPS)-0.27

Balance Sheet

CNY

As of September 30, 2026, Jiangsu Apon Medical Technology Co. Ltd. Class A holds 81.19M in cash and equivalents against 127.45M in total debt, resulting in a net debt position of 18.27M. Total book value stands at 650.72M, with working capital of 152.95M providing operational flexibility.

Cash & Cash Equivalents81.19M
Total Debt127.45M
Net Debt18.27M
Equity (Book Value)650.72M
Book Value Per Share5.16
Working Capital152.95M

Cash Flow

CNY

These figures cover the twelve months ended September 30, 2026.

Capital Expenditures-7.50M

Margins

Over the twelve months ended September 30, 2026, Jiangsu Apon Medical Technology Co. Ltd. Class A posted a gross margin of 69.09, reflecting its pricing power and cost economics. The operating margin of -9.66 and net profit margin of -9.08 provide insight into operational efficiency.

Gross Margin69.09
Operating Margin-9.66
Pretax Margin-10.32
Profit Margin-9.08
EBITDA Margin-9.77

Dividends & Yields

CNY

Over the twelve months ended September 30, 2026, Jiangsu Apon Medical Technology Co. Ltd. Class A paid dividends of 0.01 per share. The dividend payout ratio of -4.73 is negative because earnings are negative, so the dividend is being paid out of something other than profits, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Total shareholder yield is negative at -0.39, meaning Jiangsu Apon Medical Technology Co. Ltd. Class A raised more capital through share issuance and new debt than it returned via dividends and buybacks.

Dividend Per Share0.01
Payout Ratio-4.73
Shareholder Yield-0.39

Stock Splits

Jiangsu Apon Medical Technology Co. Ltd. Class A's most recent stock split took place on June 2, 2021 with a 5:6 split ratio.

Last Split Date6/2/2021
Split Ratio5:6

Scores

As of September 30, 2026, Jiangsu Apon Medical Technology Co. Ltd. Class A has an Altman Z-Score of 9.79, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score9.79